FDA MedWatch

UPDATE - FDA expanded its nationwide alert to consumers about tainted weight loss products containing undeclared, active pharmaceutical ingredients.

Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products (updated)

Nationwide recall of supplement, found to contain an undeclared drug, which may cause life-threatening risk of sudden drop in blood pressure.

Sharing of insulin pens may result in transmission of hepatitis viruses, HIV, or other blood-borne pathogens.

Drugs@FDA Downloadable Data Files (updated)

Devices may experience low energy shock, unexpected device shutdown, and/or susceptibility to electromagnetic noise interference, preventing defibrillation of a patient in cardiac arrest.

Class 1 Recall issued because software and battery usage failures were identified that result in a delay in or interruption of infusion that may cause serious injury and/or death.